Zenyaku Kogyo Kabushiki Kaisha
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Dec 26, 2017 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 423 Total Citation Count
- Aug 18, 1980 Earliest Filing
- 33 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9089561 Methods for treating depression, neurodegeneration, inhibiting amyloid β deposition, delaying senescence, and extending life spans with heterocyclic compoundsFeb 12, 14Jul 28, 15[A61K, C07D]
8338414 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredientMay 24, 10Dec 25, 12[A61K, A01N, C07D, A61P]
8227463 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the sameNov 21, 08Jul 24, 12[A61K, C07D]
7855199 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredientMar 30, 05Dec 21, 10[A61K, C07D]
7767824 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredientMay 15, 06Aug 03, 10[A61K, C07D]
7750001 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredientAug 30, 07Jul 06, 10[A61K, C07D, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8563715 Pyrimidine derivative having cell protecting effect and uses thereofExpiredMar 31, 09Oct 22, 13[A61K, C07D, A61P]
2012/0083,486 KIT, COMPOSITION, PRODUCT OR MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENTAbandonedDec 15, 11Apr 05, 12[A61K, A61P]
2011/0059,998 KIT, COMPOSITION, PRODUCT OR MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENTAbandonedFeb 27, 09Mar 10, 11[A61K, A61P]
2010/0298,348 Method of Decreasing Ubiquitylated Protein LevelsAbandonedMay 11, 10Nov 25, 10[A61K, C12Q, A61P]
2010/0267,763 Method of Decreasing Pro-ADAM10 Secretase and/or Beta Secretase LevelsAbandonedApr 14, 10Oct 21, 10[A61K, A61P]
2010/0168,135 Method of Inducing Cleavage of Amyloid Precursor Protein to Form a Novel FragmentAbandonedDec 15, 09Jul 01, 10[A61K, C12Q, C07K]
2008/0103,157 METHODS FOR TREATING DEPRESSION, NEURODEGENERATION, INHIBITING AMYLOID BETA DEPOSITION, DELAYING SENESCENCE, AND EXTENDING LIFE SPANS WITH HETEROCYCLIC COMPOUNDSAbandonedOct 15, 07May 01, 08[A61K, A61P]
2008/0103,158 METHODS FOR TREATING DELAYING THE PROGRESSION OF ALZHEIMER'S DISEASE WITH HETEROCYCLIC COMPOUNDSAbandonedOct 15, 07May 01, 08[A61K, A61P]
2007/0244,110 Treatment of prostate cancer, melanoma or hepatic cancerAbandonedApr 14, 06Oct 18, 07[A61K]
6897304 Cephem compounds and ESBL-detecting reagents containing the sameExpiredSep 21, 01May 24, 05[C12Q, C07D]
5773449 Thioquinolone compounds which have useful pharmaceutical activityExpiredApr 07, 97Jun 30, 98[A61K, C07D]
5574033 Heterocyclic compound and cardiotonic agent containing the same as effective componentExpiredJul 21, 95Nov 12, 96[A61K, C07D]
5489591 S-triazine derivative and remedy for estrogen-dependent disease containing said derivative as effective componentExpiredAug 29, 94Feb 06, 96[A61K, C07D]
5446042 Heterocyclic compound and cardiotonic agent containing the same as effective componentExpiredMay 27, 94Aug 29, 95[A61K, C07D]
5112833 1-azaindolizine derivatives, synthetic intermediates thereof and antiallergic agents containing 1-azaindolizine derivativesExpiredJun 26, 91May 12, 92[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.